glycine has been researched along with Angiogenesis, Pathologic in 18 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Glycine is a non-toxic amino acid with suspected anti-angiogenic effects." | 5.43 | Glycine inhibits angiogenesis in colorectal cancer: role of endothelial cells. ( Bruns, H; Kazanavicius, D; Saeedi, MA; Schemmer, P; Schultze, D; Strupas, K; Yamanaka, K, 2016) |
| "Glycine is a non-toxic amino acid with suspected anti-angiogenic effects." | 1.43 | Glycine inhibits angiogenesis in colorectal cancer: role of endothelial cells. ( Bruns, H; Kazanavicius, D; Saeedi, MA; Schemmer, P; Schultze, D; Strupas, K; Yamanaka, K, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Warden, C | 1 |
| Brantley, MA | 1 |
| Guo, D | 1 |
| Murdoch, CE | 1 |
| Xu, H | 1 |
| Shi, H | 1 |
| Duan, DD | 1 |
| Ahmed, A | 1 |
| Gu, Y | 1 |
| Hitzel, J | 1 |
| Lee, E | 1 |
| Zhang, Y | 1 |
| Bibli, SI | 1 |
| Li, X | 1 |
| Zukunft, S | 1 |
| Pflüger, B | 1 |
| Hu, J | 1 |
| Schürmann, C | 1 |
| Vasconez, AE | 1 |
| Oo, JA | 1 |
| Kratzer, A | 1 |
| Kumar, S | 1 |
| Rezende, F | 1 |
| Josipovic, I | 1 |
| Thomas, D | 1 |
| Giral, H | 1 |
| Schreiber, Y | 1 |
| Geisslinger, G | 1 |
| Fork, C | 1 |
| Yang, X | 1 |
| Sigala, F | 1 |
| Romanoski, CE | 1 |
| Kroll, J | 1 |
| Jo, H | 1 |
| Landmesser, U | 1 |
| Lusis, AJ | 1 |
| Namgaladze, D | 1 |
| Fleming, I | 1 |
| Leisegang, MS | 1 |
| Zhu, J | 1 |
| Brandes, RP | 1 |
| Zhu, Y | 1 |
| Wang, Y | 1 |
| Jia, Y | 1 |
| Xu, J | 1 |
| Chai, Y | 1 |
| Jin, X | 1 |
| Han, D | 1 |
| Tao, J | 1 |
| Huang, Y | 1 |
| Zhou, Z | 1 |
| Zhang, Z | 1 |
| Qi, X | 1 |
| Jia, W | 1 |
| Min, Z | 1 |
| Shichang, Z | 1 |
| Chen, X | 1 |
| Yufang, Z | 1 |
| Changqing, Z | 1 |
| Bruns, H | 1 |
| Kazanavicius, D | 1 |
| Schultze, D | 1 |
| Saeedi, MA | 1 |
| Yamanaka, K | 1 |
| Strupas, K | 1 |
| Schemmer, P | 1 |
| Wickström, M | 1 |
| Larsson, R | 1 |
| Nygren, P | 1 |
| Gullbo, J | 1 |
| Elliott, MA | 1 |
| Ford, SJ | 1 |
| Prasad, E | 1 |
| Dick, LJ | 1 |
| Farmer, H | 1 |
| Hogg, PJ | 1 |
| Halbert, GW | 1 |
| McCarty, MF | 1 |
| Yokoyama, Y | 1 |
| Ramakrishnan, S | 1 |
| Belvisi, L | 1 |
| Riccioni, T | 1 |
| Marcellini, M | 1 |
| Vesci, L | 1 |
| Chiarucci, I | 1 |
| Efrati, D | 1 |
| Potenza, D | 1 |
| Scolastico, C | 1 |
| Manzoni, L | 1 |
| Lombardo, K | 1 |
| Stasi, MA | 1 |
| Orlandi, A | 1 |
| Ciucci, A | 1 |
| Nico, B | 1 |
| Ribatti, D | 1 |
| Giannini, G | 1 |
| Presta, M | 1 |
| Carminati, P | 1 |
| Pisano, C | 1 |
| Yamashina, S | 2 |
| Ikejima, K | 2 |
| Enomoto, N | 1 |
| Takei, Y | 1 |
| Sato, N | 2 |
| Rusyn, I | 1 |
| Downie, LE | 1 |
| Pianta, MJ | 1 |
| Vingrys, AJ | 1 |
| Wilkinson-Berka, JL | 1 |
| Fletcher, EL | 1 |
| Lozonschi, L | 1 |
| Sunamura, M | 1 |
| Kobari, M | 1 |
| Egawa, S | 1 |
| Ding, L | 1 |
| Matsuno, S | 1 |
| Rose, ML | 1 |
| Madren, J | 1 |
| Bunzendahl, H | 1 |
| Thurman, RG | 1 |
| Benelli, R | 1 |
| Barbero, A | 1 |
| Ferrini, S | 1 |
| Scapini, P | 1 |
| Cassatella, M | 1 |
| Bussolino, F | 1 |
| Tacchetti, C | 1 |
| Noonan, DM | 1 |
| Albini, A | 1 |
2 reviews available for glycine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Aminopeptidase N (CD13) as a target for cancer chemotherapy.
Topics: CD13 Antigens; Cell Proliferation; Clinical Trials as Topic; Glycine; Humans; Hydroxamic Acids; Leuc | 2011 |
Glycine as a therapeutic immuno-nutrient for alcoholic liver disease.
Topics: Calcium Channels; Endothelial Cells; Glycine; Humans; Immunologic Factors; Kupffer Cells; Liver; Liv | 2005 |
1 trial available for glycine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Pharmaceutical development of the novel arsenical based cancer therapeutic GSAO for Phase I clinical trial.
Topics: Angiogenesis Inhibitors; Antioxidants; Arsenicals; Calorimetry, Differential Scanning; Chemistry, Ph | 2012 |
15 other studies available for glycine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Glycine-Conjugated Bile Acids Protect RPE Tight Junctions against Oxidative Stress and Inhibit Choroidal Endothelial Cell Angiogenesis In Vitro.
Topics: Angiogenesis Inhibitors; Animals; Bile Acids and Salts; Cell Culture Techniques; Cell Movement; Cell | 2021 |
Vascular endothelial growth factor signaling requires glycine to promote angiogenesis.
Topics: Animals; Glycine; Glycine Plasma Membrane Transport Proteins; HEK293 Cells; Human Umbilical Vein End | 2017 |
Oxidized phospholipids regulate amino acid metabolism through MTHFD2 to facilitate nucleotide release in endothelial cells.
Topics: Amino Acids; Aminohydrolases; Animals; Aorta; Atherosclerosis; Bayes Theorem; Cardiovascular Disease | 2018 |
Roxadustat promotes angiogenesis through HIF-1α/VEGF/VEGFR2 signaling and accelerates cutaneous wound healing in diabetic rats.
Topics: Angiogenesis Inducing Agents; Animals; Blotting, Western; Cells, Cultured; Diabetes Mellitus, Experi | 2019 |
Dimethyloxallyl Glycine-Incorporated Borosilicate Bioactive Glass Scaffolds for Improving Angiogenesis and Osteogenesis in Critical-Sized Calvarial Defects.
Topics: Animals; Boron Compounds; Glass; Glycine; Humans; Male; Neovascularization, Pathologic; Optical Imag | 2019 |
3D-printed dimethyloxallyl glycine delivery scaffolds to improve angiogenesis and osteogenesis.
Topics: 3-Hydroxybutyric Acid; Angiogenesis Inducing Agents; Biocompatible Materials; Bone and Bones; Bone M | 2015 |
Glycine inhibits angiogenesis in colorectal cancer: role of endothelial cells.
Topics: Animals; Colorectal Neoplasms; Glycine; Human Umbilical Vein Endothelial Cells; Humans; Neovasculari | 2016 |
A wholly nutritional 'multifocal angiostatic therapy' for control of disseminated cancer.
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Copper; Cyclic AMP; Diet; Diet, Vege | 2003 |
Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Arginine; Asparagine; CD13 Antigens; Cell L | 2005 |
Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist.
Topics: Animals; Antineoplastic Agents; Arginine; Aspartic Acid; Cattle; Cell Adhesion; Cell Line, Tumor; Ce | 2005 |
Glycine as a potent anti-angiogenic nutrient for tumor growth.
Topics: Calcium; Cell Movement; Chloride Channels; Endothelium, Vascular; Glycine; Humans; In Vitro Techniqu | 2007 |
Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Gliosis; Glutamic Acid; Glycine; Humans; Hyperoxi | 2007 |
Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Glycine; Hydroxamic Acids; Lung Neoplasms; Male; Metallo | 1999 |
Dietary glycine inhibits the growth of B16 melanoma tumors in mice.
Topics: Animals; Cell Division; Cell Line; Diet; Glycine; Melanoma; Mice; Neovascularization, Pathologic; Sk | 1999 |
Human immunodeficiency virus transactivator protein (Tat) stimulates chemotaxis, calcium mobilization, and activation of human polymorphonuclear leukocytes: implications for Tat-mediated pathogenesis.
Topics: Amino Acid Substitution; Animals; Arginine; Aspartic Acid; Calcium; Cells, Cultured; Chemotaxis, Leu | 2000 |